resin

Small moleculeexperimental

A resin is a solid or highly viscous liquid that can be converted into a polymer. Resins may be biological or synthetic in origin, but are typically harvested from plants. Resins are mixtures of organic compounds insoluble in water, predominantly terpenes. Technically, resins should not be confused with gums, which consist predominantly of water-soluble polysaccharides, although these two terms are often interchangeable in the less formal context. Common resins include pine oleoresins, amber, hashish, frankincense, myrrh and the animal-derived resin, shellac. Resins are used in varnishes, adhesives, food additives, incenses and perfumes. — Wikipedia

Clinical trial activity

4 trials · 5 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
2

Earliest trial started Jan 1, 2008 (NCT01417832)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 2 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • resin
  • resin

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02912741Phase 2Jan 1, 2017Cairo University
NCT03034837Phase 4Jan 1, 2016Zhengzhou University
NCT01851590Phase 4Oct 1, 2013Repolar Ltd., University of Helsinki
NCT01417832Phase 2/Phase 3 (Phase 3)Jan 1, 2008Universidad El Bosque, Bogotá
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (5)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Cairo UniversityAcademic/Hospital1112017
Repolar Ltd.For profit1012013
Universidad El Bosque, BogotáAcademic/Hospital1112008
University of HelsinkiAcademic/Hospital1112013
Zhengzhou UniversityAcademic/Hospital1112016
5 organizations
Page 1 / 1